BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22537823)

  • 1. Predicting warfarin dosage from clinical data: a supervised learning approach.
    Hu YH; Wu F; Lo CL; Tai CT
    Artif Intell Med; 2012 Sep; 56(1):27-34. PubMed ID: 22537823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of adequate use of warfarin for the elderly using decision tree-based approaches.
    Liu KE; Lo CL; Hu YH
    Methods Inf Med; 2014; 53(1):47-53. PubMed ID: 24136011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting Warfarin Dosing Using Machine Learning Techniques.
    Sharabiani A; Bress A; Douzali E; Darabi H
    Comput Math Methods Med; 2015; 2015():560108. PubMed ID: 26146514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of anticoagulant treatment using a dynamic decision support algorithm: a Danish Cohort study.
    Nielsen PB; Lundbye-Christensen S; Rasmussen LH; Larsen TB
    Thromb Res; 2014 Mar; 133(3):375-9. PubMed ID: 24444650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of the pharmacogenetic dosing table in the warfarin label in predicting initial therapeutic warfarin doses in a large, racially diverse cohort.
    Shin J; Kayser SR
    Pharmacotherapy; 2011 Sep; 31(9):863-70. PubMed ID: 21923587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database.
    Liu R; Li X; Zhang W; Zhou HH
    PLoS One; 2015; 10(8):e0135784. PubMed ID: 26305568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of an algorithm for oral anticoagulant dosing and appointment scheduling.
    Vadher BD; Patterson DL; Leaning MS
    Clin Lab Haematol; 1995 Dec; 17(4):339-45. PubMed ID: 8697730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
    Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
    Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable warfarin dose prediction in sub-Saharan African patients: A machine-learning approach and external validation of a clinical dose-initiation algorithm.
    Asiimwe IG; Blockman M; Cohen K; Cupido C; Hutchinson C; Jacobson B; Lamorde M; Morgan J; Mouton JP; Nakagaayi D; Okello E; Schapkaitz E; Sekaggya-Wiltshire C; Semakula JR; Waitt C; Zhang EJ; Jorgensen AL; Pirmohamed M
    CPT Pharmacometrics Syst Pharmacol; 2022 Jan; 11(1):20-29. PubMed ID: 34889080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-objective feature selection for warfarin dose prediction.
    Sohrabi MK; Tajik A
    Comput Biol Chem; 2017 Aug; 69():126-133. PubMed ID: 28689108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients.
    Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA
    Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hemorrhage and treatment costs associated with warfarin drug interactions in patients with atrial fibrillation.
    Suh DC; Nelson WW; Choi JC; Choi I
    Clin Ther; 2012 Jul; 34(7):1569-82. PubMed ID: 22717419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study.
    Lee HL; Kan CD; Yang YJ
    Clin Ther; 2005 Mar; 27(3):309-19. PubMed ID: 15878384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin.
    Kovac M; Mitic G; Kovac Z
    J Clin Pharm Ther; 2012 Feb; 37(1):45-8. PubMed ID: 21332566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching.
    Halkin H; Shapiro J; Kurnik D; Loebstein R; Shalev V; Kokia E
    Clin Pharmacol Ther; 2003 Sep; 74(3):215-21. PubMed ID: 12966365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.
    Nutescu EA; Bathija S; Sharp LK; Gerber BS; Schumock GT; Fitzgibbon ML
    Pharmacotherapy; 2011 Dec; 31(12):1161-74. PubMed ID: 22122179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of computerized decision support for oral anticoagulation management based in primary care.
    Fitzmaurice DA; Hobbs FD; Murray ET; Bradley CP; Holder R
    Br J Gen Pract; 1996 Sep; 46(410):533-5. PubMed ID: 8917873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
    Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
    Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying an artificial neural network to warfarin maintenance dose prediction.
    Solomon I; Maharshak N; Chechik G; Leibovici L; Lubetsky A; Halkin H; Ezra D; Ash N
    Isr Med Assoc J; 2004 Dec; 6(12):732-5. PubMed ID: 15609884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.